‘R&D continues to be the key driver for sustained growth’—Kushal Suri, Head International…
More than three decades old, research-oriented API manufacturing pharmaceutical company Morepen Laboratories has established its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Morepen Laboratories
Browsing Tag
Morepen Laboratories
Morepen Laboratories reports net sales revenue of Rs 196.60 crore in Q2’FY 2019-20
The company's pharma division commenced commercial sales of its probiotics in India during Q1 FY 2019-20 and has made steady…
Morepen Labs adds three new drugs to its API Portfolio
The three bulk drugs/APIs are Rivaroxaban, Vildagliptin and UDCA will augment Morepen’s presence in the cardiac and diabetic…
API barcoding Benefits and bottelenecks
Recently, the Union Health Ministry announced that the government will make it mandatory for all API packages to be barcoded and…
Kushal Suri, Head- International Business Development, Morepen Laboratories
At the very outset we warmly welcome this decision by the government alongside inputs and crackdown by the CDSCO to track all…
Morepen to sell Montelukast in Europe, North America
The company is eyeing Rs 100 crore global turnover in 2016-17 from this product